par Prenen, Hans;Gil, Thierry 
;Awada, Ahmad
Référence Critical reviews in oncology/hematology, 69, 1, page (56-63)
Publication Publié, 2009-01
;Awada, Ahmad Référence Critical reviews in oncology/hematology, 69, 1, page (56-63)
Publication Publié, 2009-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Prenen, Hans; Gil, Thierry; Awada, Ahmad |
| Informations sur la publication: | Critical reviews in oncology/hematology, 69, 1, page (56-63) |
| Statut de publication: | Publié, 2009-01 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Angiogenesis |
| Molecular targeted therapy | |
| Renal cell cancer | |
| Sorafenib | |
| Sunitinib | |
| Temsirolimus | |
| MeSH keywords: | Antineoplastic Agents -- therapeutic use |
| Cancer Vaccines -- immunology | |
| Carcinoma, Renal Cell -- drug therapy | |
| Carcinoma, Renal Cell -- immunology | |
| Carcinoma, Renal Cell -- pathology | |
| Carcinoma, Renal Cell -- therapy | |
| Humans | |
| Immunotherapy | |
| Kidney Neoplasms -- drug therapy | |
| Kidney Neoplasms -- immunology | |
| Kidney Neoplasms -- pathology | |
| Kidney Neoplasms -- therapy | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8428 |
| info:doi/10.1016/j.critrevonc.2008.07.007 | |
| info:pii/S1040-8428(08)00147-9 | |
| info:scp/56449119798 | |
| info:pmid/18752971 |
